Orkla ASA
Orkla ASA (ORKLY) Financial Performance & Income Statement Overview
Review Orkla ASA (ORKLY) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Orkla ASA (ORKLY) Income Statement & Financial Overview
Analyze Orkla ASA’s ORKLY earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $17.18B | $18.79B | $17.51B | $17.24B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $17.18B | $18.79B | $17.51B | $17.24B |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $15.43B | $16.97B | $16.11B | $14.86B |
| Total Costs & Expenses | $15.43B | $16.97B | $16.11B | $14.86B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $227.00M | $234.00M | $274.00M | $268.00M |
| Depreciation & Amortization | $656.00M | $742.00M | $699.00M | $678.00M |
| EBITDA | $3.04B | $2.92B | $2.64B | $3.59B |
| EBITDA Ratio | $0.18 | $0.16 | $0.15 | $0.21 |
| Operating Income | $1.75B | $1.83B | $1.41B | $2.39B |
| Operating Income Ratio | $0.10 | $0.10 | $0.08 | $0.14 |
| Other Income/Expenses (Net) | $411.00M | $121.00M | $265.00M | $254.00M |
| Income Before Tax | $2.16B | $1.95B | $1.67B | $2.64B |
| Income Before Tax Ratio | $0.13 | $0.10 | $0.10 | $0.15 |
| Income Tax Expense | $405.00M | $496.00M | $385.00M | $492.00M |
| Net Income | $1.79B | $1.36B | $1.19B | $2.04B |
| Net Income Ratio | $0.10 | $0.07 | $0.07 | $0.12 |
| EPS | $1.80 | $1.36 | $1.19 | $2.05 |
| Diluted EPS | $1.79 | $1.36 | $1.18 | $2.04 |
| Weighted Avg Shares Outstanding | $997.05M | $999.59M | $998.93M | $998.10M |
| Weighted Avg Shares Outstanding (Diluted) | $999.48M | $1.002B | $1.001B | $999.05M |
The company's financials show resilient growth, with revenue advancing from $17.24B in Q2 2024 to $17.18B in Q1 2025. Gross profit remained healthy with margins at 100% in Q1 2025 compared to 100% in Q2 2024. Operating income hit $1.75B last quarter, sustaining a consistent 10% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $3.04B. Net income rose to $1.79B, while earnings per share reached $1.80. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan